These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37194387)

  • 61. Can proton therapy reduce radiation-related lymphopenia in glioblastoma?
    Huang J; Mehta M
    Neuro Oncol; 2021 Feb; 23(2):179-181. PubMed ID: 33263752
    [No Abstract]   [Full Text] [Related]  

  • 62. Modelling recurrence and second cancer risks induced by proton therapy.
    Manem VSK; Dhawan A
    Math Med Biol; 2018 Sep; 35(3):347-361. PubMed ID: 29106564
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Review of Proton Therapy - Current Status and Future Directions.
    Mohan R
    Precis Radiat Oncol; 2022 Jun; 6(2):164-176. PubMed ID: 36160180
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
    Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
    Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relative biological effectiveness (RBE) values for proton beam therapy.
    Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proton Radiation Biology Considerations for Radiation Oncologists.
    Woodward WA; Amos RA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):59-61. PubMed ID: 27084628
    [No Abstract]   [Full Text] [Related]  

  • 67. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined proton-photon treatment for breast cancer.
    Marc L; Fabiano S; Wahl N; Linsenmeier C; Lomax AJ; Unkelbach J
    Phys Med Biol; 2021 Nov; 66(23):. PubMed ID: 34736246
    [No Abstract]   [Full Text] [Related]  

  • 69. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Promise and pitfalls of heavy-particle therapy.
    Mitin T; Zietman AL
    J Clin Oncol; 2014 Sep; 32(26):2855-63. PubMed ID: 25113772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Place of proton radiotherapy in future radiotherapy practice.
    Zips D; Baumann M
    Semin Radiat Oncol; 2013 Apr; 23(2):149-53. PubMed ID: 23473693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comparison of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions.
    Baumert BG; Lomax AJ; Miltchev V; Davis JB
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1439-49. PubMed ID: 11286852
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Absorption characteristics of protons and photons in tissue.
    Dicello JF
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):25-9. PubMed ID: 17668948
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Why proton therapy? And how?].
    Thariat J; Habrand JL; Lesueur P; Chaikh A; Kammerer E; Lecomte D; Batalla A; Balosso J; Tessonnier T
    Bull Cancer; 2018 Mar; 105(3):315-326. PubMed ID: 29422248
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A challenge for high-precision radiation therapy: the case for photons.
    Gahbauer RA
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():121-2. PubMed ID: 10394419
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Double scattering and pencil beam scanning Monte Carlo workflows for proton therapy retrospective studies on radiation-induced toxicities.
    Leite AMM; Bonfrate A; Da Fonseca A; Lansonneur P; Alapetite C; Mammar H; De Marzi L
    Cancer Radiother; 2023 Jun; 27(4):319-327. PubMed ID: 37164897
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
    Mohan R; Liu AY; Brown PD; Mahajan A; Dinh J; Chung C; McAvoy S; McAleer MF; Lin SH; Li J; Ghia AJ; Zhu C; Sulman EP; de Groot JF; Heimberger AB; McGovern SL; Grassberger C; Shih H; Ellsworth S; Grosshans DR
    Neuro Oncol; 2021 Feb; 23(2):284-294. PubMed ID: 32750703
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proton Therapy in Non-small Cell Lung Cancer.
    Mesko S; Gomez D
    Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.